Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

Health, Fitness & Food

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. 
Scott Olson | Getty Images

New trial data has cemented Club holding Eli Lilly‘s pole position in the highly competitive obesity drug race.

Products You May Like

Articles You May Like

How to Build a Meal for VEGAN Weight Loss – (Plate Breakdown)
Start Your Day Right with High Protein Smoothies!
Full body weight loss workout 💪🏻💪🏻💪🏻
Weight Training Is Bad For Weight Loss?
U.S. surgeon general calls for cancer risk warnings on alcohol labels

Leave a Reply

Your email address will not be published. Required fields are marked *